相关实验视频

Updated: Jul 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

专家网:一种深度学习方法,用于在重症监护病房组合风险建模和亚型化

Shivin Srivastava, Vaibhav Rajan

    IEEE journal of biomedical and health informatics
    |October 11, 2023
    PubMed
    概括

    专家网 (ExpertNet) 是一种新的深度学习模型,通过同时对患者进行集群和分类风险,改善了重症监护室 (ICU) 的疾病风险预测. 这种方法增强了针对败血症和急性呼吸困扰综合征 (ARDS) 等疾病的个性化药物.

    更多相关视频

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack07:31

    Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

    Published on: May 15, 2020

    7.1K
    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.1K

    相关概念视频

    Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

    Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

    Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
    One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
    78
    Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

    Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

    Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
    The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
    79
    Clearance Models: Noncompartmental Models01:17

    Clearance Models: Noncompartmental Models

    Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
    The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
    64
    Model Approaches for Pharmacokinetic Data: Compartment Models01:14

    Model Approaches for Pharmacokinetic Data: Compartment Models

    Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
    Two primary types of compartment models are recognized: mammillary and catenary. The more...
    112
    Relative Risk01:12

    Relative Risk

    Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
    191
    Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

    Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

    Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
    The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
    155